» Articles » PMID: 32469400

Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia

Overview
Journal JAMA Neurol
Date 2020 May 30
PMID 32469400
Citations 204
Authors
Affiliations
Soon will be listed here.
Citing Articles

Neurological syndromes associated with COVID-19: a multicenter study in Brazil.

Matos A, Gomes A, Carvalho F, de Oliveira F, da Silva L, Dahy F BMC Infect Dis. 2025; 25(1):123.

PMID: 39871154 PMC: 11770952. DOI: 10.1186/s12879-025-10504-6.


Olfactory Epithelium Infection by SARS-CoV-2: Possible Neuroinflammatory Consequences of COVID-19.

Gutierrez-Garcia A, Contreras C Complex Psychiatry. 2024; 10(1-4):59-70.

PMID: 39545135 PMC: 11560153. DOI: 10.1159/000540982.


Clinical significance of MRI-measured olfactory bulb height as an imaging biomarker of idiopathic Parkinson's disease.

Park S, Lee J, Kim J, Park J, Lee J, Park S PLoS One. 2024; 19(10):e0312728.

PMID: 39466765 PMC: 11515979. DOI: 10.1371/journal.pone.0312728.


Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review.

Mehraeen E, Yarmohammadi S, Mirzapour P, Tamehri Zadeh S, Dehghani S, Molaeipour L Int Arch Otorhinolaryngol. 2024; 28(4):e728-e743.

PMID: 39464360 PMC: 11511580. DOI: 10.1055/s-0044-1786046.


Role of Imaging in Diagnosis and Management of COVID-19: Evidence-Based Approaches.

Pezzutti D, Makary M Adv Exp Med Biol. 2024; 1457:237-246.

PMID: 39283430 DOI: 10.1007/978-3-031-61939-7_13.